Researchers Engineered Nitrene Synthesis in Bacteria
A new biosynthetic network enables Escherichia coli to produce amino alcohols and diamines.
Updated on Sept. 22, 2026 in Life Sciences
Live Poll
Do you believe synthetic biology research will ultimately make essential medicines more affordable?
Researchers have successfully constructed an artificial biosynthetic network within Escherichia coli to facilitate nitrene reactions. This innovation allows the bacteria to synthesize useful chemical compounds, including amino alcohols and diamines, from simple carbon and nitrogen sources.
Why it matters
The development represents a significant advancement in biocatalysis by integrating metabolic engineering with chemical nitrene-transfer technology. By utilizing sustainable, inexpensive precursors, this method offers a potential pathway for the greener manufacturing of complex organic molecules.
The process achieved a 90% enantiomeric excess in amino alcohol products. This was realized through engineered metabolic pathways and the use of cytochrome P450 nitrene-transfer catalysts to activate precursors derived from p-aminobenzoic acid.
The players
Escherichia coli
This bacterium serves as the biological host for the newly constructed biosynthetic network.
Nature Catalysis
This peer-reviewed scientific journal publishes high-impact research regarding catalysis.
The details
The research team utilized the arylamine oxygenase BezJ and the acetyltransferase BezG to mediate the biosynthesis of nitrene precursors. These precursors are subsequently activated by BezE family cytochrome P450 enzymes to produce targeted amino alcohols and diamines from vinyl arenes.
Timeline
September 2026: The research was published in Nature Catalysis.
The Big Picture
This discovery shifts the trajectory of metabolic engineering by proving that highly specific nitrene chemistry can be maintained within a biological host. It successfully bridges gaps between chemical synthesis and synthetic biology, potentially unlocking new research into sustainable manufacturing of pharmaceutical building blocks.
This breakthrough could eventually lead to more cost-effective and environmentally friendly production methods for essential chemicals and pharmaceutical ingredients. Future applications may result in the cheaper synthesis of complex molecular structures that currently require hazardous chemical reagents.
The takeaway
The successful use of engineered E. coli for complex nitrene chemistry highlights the growing potential for biological systems to replace traditional chemical manufacturing methods. This approach emphasizes that sustainable, high-precision chemical synthesis can be achieved through directed evolution and metabolic pathway design.
Further reading
Discover more about modern developments in the field of Life Sciences.
Live Poll
Do you believe synthetic biology research will ultimately make essential medicines more affordable?
